Stay updated on Venetoclax Combo vs Azacitidine in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax Combo vs Azacitidine in AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added about the website transition and the use of “Super Intelligence” instead of “Artificial Intelligence.” The site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:24:18.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:26:00.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, blocking access to the study record. Previously visible trial details and related content are no longer accessible, replaced by an error layout.
    Difference
    19%
    Check dated 2026-09-23T00:28:01.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, representing a new revision of the page metadata rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-09-15T23:37:14.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, signaling an administrative update to the ClinicalTrials.gov entry. No substantive study information or user-facing content appears to have changed.
    Difference
    0.0%
    Check dated 2026-09-01T18:23:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new NIH grant/contract reference was added to the study's identifier list, indicating funding attribution without changing the study’s design or participation criteria.
    Difference
    0.0%
    Check dated 2026-08-25T19:45:25.000Z thumbnail image

Stay in the know with updates to Venetoclax Combo vs Azacitidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.